cals, Piscataway, N J; trasylol, bovine serum albumin (BSA), a-phorbol 12-myristate 13-acetate (PMA) from Sigma Chemical Co. (St. Louis, MO); oligo (dT) cellulose type 77 from PL Biochemicals; tissue culture plasticware from Falcon Labware Div. of Becton, Dickinson and Co., Oxnard, CA. Alu Gel S (2% suspension) from Accurate Chemical and Scientific Corp., Westbury, NY. All reagents were of the highest grade commercially available.
Antibody Production. Antibodies to IL-2 were raised in rabbits. Purified IL-2 fraction VI (7) (1-10 #g) was mixed I:1 with Alu Gel and injected intradermaUy on the back of the animal in 30 different sites. Identical booster injections were administered every 4 wk. Antibody responses were detectable 2-3 months after the first injection.
Mixed Leukocytic Reaction (MLR).
The effect of anti-IL-2 on antigen-induced T cell proliferation was tested in primary MLR using replicate 100 #1 cultures (MEM, 5% heatinactivated fetal calf serum (FCS), 5 × 10 -s M 2-mercaptoethanol, and antibiotics) of 1 × 106 cells/ml C57B1]6 responder spleen cells and 1.5 × 106 cells/mi BALB/c irradiated (1,000 rad) splenic stimulator cells. Replicate cultures were supplemented with varying concentrations of either anti-IL-2 Ig or preimmune Ig. After 5 d of culture (37°C in a humidified atmosphere of 10% CO2, 7% 02, and 83% nitrogen), cells were exposed to a 4-h pulse of 1.7 #Ci [3H] TdR. The cultures were then collected onto glass fiber strips using a Brandeil cell harvester and [SH] TdR incorporation was determined by liquid scintillation counting in liquifluor toluene. For CTL response viable effector cells were tested for their ability to lyse 5|Cr-labeled allogeneic P815 target cells.
Preparation of Conditioned Medium Rich in IL-2.
Conditioned medium from Con Aactivated spleen cells were prepared as described elsewhere (7) . Conditioned medium from blast cells was prepared by plating 2 x 106 3-d Con A-stimulated spleen cells in 35-mm cultures in 1 ml of MEM medium containing 5 x 10 -5 M 2-mercaptoethanol, and 5 #g/ml Con A. After 2 h the Con A-induced cell monolayers were washed to remove Con A and the medium replenished with 2 ml of MEM plus 5 x 10 -5 M 2-mercaptoethanol. Cell-free supernatant media were harvested at the desired time, centrifuged to remove cell debris, and stored at -20°C.
Assay for T Helper Activity. Antibody synthesis was measured as described by Mishell and Dutton (8) . Spleen cells from BALB/c, BALB/c nu/nu, and C57bl]6 mice were resuspended in MEM supplemented with 5% FCS to a density of 5 X 108 cells/ml and distributed into 35-mm plates; 50 ~1 of 0.5% sheep erythrocytes (SRBC) were added as antigen to each culture. Immune or preimmune Ig or IL-2 were added at the desired concentration on day 0 or day 2. The culture was incubated with gentle rocking for 5 d and the cells were harvested and assayed for the antibody production in the Jerne plaque assay as modified by Mishell and Dutton (8) . The results are expressed as the number of lytic plaques formed by 106 cells.
Assay for IL-2. IL-2 activity in conditioned media was assayed on 3 d Con A-stimulated spleen cells as described previously (7). 1 U was defined as the amount of IL-2 required to double the [SH]-TdR incorporation observed in untreated cultures. Con A supernatants (containing ~ 10 U/ml of IL-2) were incubated for 2 h with or without serial dilutions of anti-IL-2 or preimmune serum and then mixed with T cell blasts (4 x 105 cells]ml). 20 h after culture initiation cells were exposed to a pulse of [SH]-TdR for 4 h.
IL-I Assay. IL-1 was assayed for its ability to stimulate the proliferative response of C3H/HJ thymocytes to phytohemagglutinin (PHA). Several dilutions of IL-l-containing supernatants produced by the J7774 macrophage cell line stimulated with lipopolysaccharide, were dispersed to individual microculture wells in 100 #l and then 100 #! of thymocytes suspension (1.5 x 107/ml) was added to each well. After 72 h cells were pulsed for 4 h with [SH]-TdR.
IL-3 Assay.
A FDC/D~ cell line, described by Ihle (9) was used as the responding cell in a proliferative assay. 2 x 104 cells were cultured in microwells with several dilutions of supernatants from the WEHI-3 cell line and the response was measured after 20 h by [SH] TdR incorporation (4 h).
Interferon Assay. Con A supernatants were titrated for their inhibition of the cytopathic effect of vesicular stomatitis virus on mouse fibroblasts line L929/B. Confluent monolayers were seeded in microtest wells with threefold dilutions of supernatant or fractions to be assayed. After 20 h of incubation an infecting dose of vesicular stomatitis virus was added. The plates were examined under the microscope to determine the last dilution of supernatant that inhibits the lysis of one-half the cells. Cytotoxic Differentiation Factor. Assay for factors necessary for the development of cytolytic T cells was performed according to Granelli-Piperno and Steinman (manuscript in preparation). 5 x 105 thymocytes from Swiss mice (4 wk old) were suspended in MEM medium supplemented with 10% heat-inactivated FCS, 5 x 10 -5 M B-mercaptoethanol, and 1 #g/ml Con A, and cultured in microwells with several dilutions of conditioned media. Polyclonal cytolytic T lymphocyte (CTL) response was measured after 72 h using 5'Cr-labeled P815 as targets in the presence of 10 #g/ml PHA. Addition to the cell cultures of purified or recombinant IL2 (Biogen), -/-IFN (Genentech), or IL-1 only did not support CTL response in this assay.
B Cell Stimulating Factor

Polyacrylamide Gel Electrophoresis (SDS-PAGE)
. SDS-PAGE was performed as described by Laemmli (11) . Conditioned medium was concentrated 10-fold over an Amicon PM-10 membrane. Samples were then mixed with an equal volume of double-strength sample buffer and electrophoresed in a 12.5% polyacrylamide slab gel. One lane of the gel was cut into 1-mm slices, eluted in phosphate-buffered saline (PBS) for 18 h at 4°C, and assayed for IL-2 activity. Protein bands were visualized by silver staining techniques (12) .
Anti-lL-2 Affinity Chromatography. Serum from immunized rabbits was diluted 1:1 with PBS and loaded onto a protein A-Sepharose column. The column was washed with PBS containing 0.4 M NaCI and the Ig fraction was eluted with 0.1 M glycine HCI, pH 2.3 and immediately neutralized with 1 M Tris. Immunoglobulin G (7.5 mg) was extensively dialyzed against coupling buffer (0.05 M MES, pH 6.5), coupled to 1.5 ml of swollen activated C NBr Sepharose, and the mixture shaken for 12-15 h at 4 o C. Residual activated groups were quenched by incubating the resin for 2 h in 1 M Tris/HC1 pH 9. Unmodified conditioned medium containing IL-2 activity was passed through the column at neutral pH, the resin was washed with 70 ml of PBS containing 0.4 M NaCi, 1% Triton X-100, 0.2% SDS, 1 mM EDTA followed by 50 ml of PBS, and IL-2 was then eluted with 0.1 M glycine HCI, pH 2.3.
Immune Precipitation of Biosynthetically Labeled IL-2. 2 × 107 spleen cells were incubated for 2 h with Con A (5 •g/ml) in serum-free medium, and the supernatant removed; methionine-deficient Dulbecco's medium containing 1/20th of the usual level of methionine and 50 #Ci/ml [35S]methionine was added and incubation continued for a further 20 h. Immunoprecipitation was then performed as follows: culture medium was made 1% in SDS and boiled for 5 min, after which Triton X-100 was added to a final concentration of 5%. The samples were immunoprecipitated for 16 h at 4°C, protein A-Sepharose was added, the mixture incubated for 30 min at room temperature and then centrifuged.The pellets were washed three times with NETTS buffer (0.5 M NaC1, 0.2% SDS, 1% Triton X-100, 1 mM EDTA, 50 mM Tris HCI, pH 7.4) and once with 0.5 M NaCI, 0.1% SDS, 50 mM Tris HCI, pH 7.4. Proteins were eluted by boiling the pellets in electrophoresis sample buffer andapplied to 12.5% SDS-PAGE.
Popliteal Lymph Node Assay. The popliteal lymph node response to antigen stimulation Isolation ofPoly A ÷ RNA. mRNA was extracted from cultured cells by the method of Lizardi and Engelberg (14) . For the preparation of RNA from EL-4 culture cells (5 x 105 cells/ml) were stimulated for 5 h with PMA (10 ng/ml) and Con A (5 #g]ml), collected by centrifugation, washed twice with PBS, and lysed with buffer A (25 mM Tris/HCl, pH 7.4, 0.1 M NaCI, 7.5 mM EDTA, 25 mg/ml polyvinyl sulfate, 2.4% SDS 350 #g/ml proteinase K; 3 ml for 1 × 108 cells) at 37°C for 15 min; then 2/3 volume of 3.5 M NaCIO4 was added and the viscosity of the solution was reduced by passing it twice through a 21-gauge needle, after which nucleic acids were precipitated with 4 vol of EPR (NaCIO4 saturated ethanol/water, 4:1) kept at 4°C for 60 min, and the precipitate collected by centrifugation at 6,000 rpm. The pellet was dissolved in buffer B (25 mM Tris/HC1, pH 7.4, 1 mM EDTA, 0.2% SDS; 8 ml for 1 × 108 cells), NaCl, was adjusted to 0.2 M, 0.6 vol of isopropanol was added, and the solution was stored at -20°C overnight. The precipitate was collected by centrifugation, the pellet resuspended in H20, 0.2 M NaCI added, and nucleic acids reprecipitated with 2.5 volumes of ethanol and stored at -20 °C overnight. The precipitate was collected as above and the pellet dissolved in H~O to a concentration of 20 OD2n0 U/ml. Lithium dodecyl sulfate was added to 0.07 %, LiCI was added to 0.2 M, and the solution was left at 4 °C for 4 h. The precipitated RNA was collected by centrifugation and reprecipitated twice with ethanol and salt. For the preparation of control RNA, cells were lysed in buffer A immediately before the addition of PMA and Con A and processed in the same way. The preparation of poly A ÷ RNA was accomplished by batchwise fractionation using oligo (dT) cellulose. RNA was dissolved in H~O to 100 OD~60 U/ml, heated at 60°C for 2 min, cooled quickly, an equal volume of 2 × HSB-buffer (HSB; 10 mM Tris/HCi, pH 7.4, 0.12 M NaCI, 1 mM EDTA, 0.20% SDS) and prewashed oligo (dT) cellulose (1 mg cellulose for 1 OD260 units) was added. After the solution was shaken for 1 h at room temperature, the resin was washed 6 times with HSB, twice with HSB minus SDS, then poly A ÷ RNA was eluted with H,O three times. For each wash the resin was collected by centrifugation at 3,000 rpm for 3 min. The eluate was precipitated with 3 vol of ethanol after adjusting 0.3 M NaCI, and the sedimented RNA dissolved in H20 and stored at -80°C. From 5 × l0 s cells 150 ~g of poly A + RNA was obtained.
Microinjection of Oocytes. 40 ng ofpoly A ÷ RNA were injected in Xenopus laevis oocytes.
Groups of 20 injected oocytes were incubated in microwells containing 200 ~1 of Barth's incubation medium (15) supplemented with BSA (0.5 mg/ml) and Trasylol (50 U/ml). After 20 h the medium was collected and centrifuged for 5 min at 12,000 g in an Eppendorf microcentrifuge, and aliquots of supernatants were assayed for IL-2 activity.
Results
To characterize the anti-IL-2 antibodies, the properties of either unfractionated antisera or purified immunoglobulins were evaluated in a series of biochemical and biological tests.
Inhibition of lL-2-dependent Lyraphoblast Proliferation. Antibodies in rabbit sera
were initially detected by an IL-2 neutralization test in which the antibody blocked the proliferation of T lymphoblasts mediated by the conditioned medium from Con A-stimulated spleen cell cultures. The action of one pool of antisera is shown in Fig. 1 , where it can be seen that immune serum completely suppressed the growth-promoting action of conditioned medium, while the same amount of preimmune rabbit serum was inert. Identical results (not shown) were obtained with the respective immunopurified immunogtobulin at final concentration of 5-10 t~g/ml.
The specificity of this inhibition for IL-2 was established by the failure of the antisera to block the action of other lymphokines, including v-interferon, IL-3 (Table I) , and B cell stimulating factor (10). action of antisera prompted us to test whether they could be used to precipitate biosynthetically radiolabeled lymphokine. The supernatant of mouse spleen cells cultures stimulated by addition of Con A and incubated for 20 h with [aSS]-methionine were immunoprecipitated with purified anti-IL-2 IgG and the washed precipitate was analyzed by SDS-PAGE. The autoradiogram in Fig. 2 shows that the immune IgG precipitate (but not that from preimmune IgG) contained a radioactive protein whose mobility yielded an apparent Mr of 23,000, which corresponds exactly with the migration of active IL-2 under the same conditions (7) . Taken together with the preceding results, this finding indicates that the antibodies both neutralize IL-2 activity and precipitate the lymphokine. Neutralization of Oocyte-translated IL-2. As a basis both for exploring the (Table II) . IL-2 activity was detectable only in the medium conditioned by oocytes that had received poly A + RNA from PMAtreated cultures, and the IL-2 was completely neutralized by the anti-IL-2 Ig. This result demonstrates the faithful translation of IL-2 m R N A in oocytes and the immunological cross-reaction of the product with lymphokine purified from spleen cell culture medium.
Immunoprecipitation of Biosynthetically
Antibodies Neutralize the Activity of Two Forms of lL-2. T h e major species of
IL-2 present in spleen cell conditioned medium, which after purification, served as immunizing antigen for raising the antisera used in this study, migrates in SDS-PAGE under nonreducing conditions with apparent Mr 23,000 (7) .
While exploring the responses of other mouse lymphoid cell populations, we observed that lymphoblasts upon stimulation with Con A released an IL-2 whose rate of migration in SDS-PAGE corresponded to Mr 20,000. This component was clearly separated from the 23-kdalton protein both during initial and subsequent electrophoresis. Although the significance of the lower molecular weight form has not been defined, we found that its mitogenic action on lymphoblasts is just as sensitive to inhibition by antibody as is that of the slower moving species. This suggests that the two are closely related, the electrophoretic difference possibly being due to differences in glycosylation or limited proteolysis. Molecular heterogeneity of IL-2 observed here is not unique because human IL-2 (16) and other cytokines, such as GM-CSF (17) , have been shown to exhibit different molecular characteristics dependent on the experimental conditions used.
Immunoaffinity Purification oflL-2. T h e anti-IL-2 immunoglobulins could be used for construction of affinity columns that effectively retained IL-2 activity. When IL-2 fractions, concentrated and slightly purified by chromatography on hydroxylapatite columns (7), were passed through such an affinity column the IL-2 activity was retained and could be recovered in good yield (20-50%) in the usual dissociating buffer (0.1 M glycine HCI, pH 2.3) (Table III, Fig. 3 ). T h e 23-kdalton component in these eluates, though highly purified, was contaminated with two other major proteins that gave bands corresponding to Mr of 60-65,000 and 90-100,000. However, mitogenicity for lymphoblasts was associated entirely with the 23-kdalton species. We note that IL-2 activity was unstable after immunoaffinity purification, with 50% loss of activity occurring within 15 d, at either acid or neutral pH, and at either 4°C or -20°C. If these fractions were further purified by SDS-PAGE, the resultant preparation were stable, without detectable loss of activity, for at least 10 months at 4 °C. Human IL-2 could not be adsorbed onto anti-mouse IL-2 column, consistent with the known antigenic differences between the two species (18) .
Interaction of Antibodies with IL-2 and Not with Other Lymphokines. Anti-IL-2 antibodies do not neutralize or absorb other soluble mediators; Table IV shows the specificity of the anti-IL-2 Ig Sepharose column. Various cell culture supernatants were fractionated on anti-IL-2 Ig Sepharose and unbound and eluted fractions assayed for the specific lymphokines. The results clearly show that the anti-IL-2 Sepharose column absorbed and purified only IL-2. All the other iymphokines testedwlL-1, IL-3, ~-IFN, B cell stimulating factor, and cytotoxic differentiation factor--were found in the unbound fractions.
Biological Effects of Anti-IL-2 Antibodies Inhibition of T Cell Mitogenesis by Anti-IL-2.
Given the capacity of anti-IL-2 antibody to inhibit IL-2-dependent T lymphoblast growth, it was of interest to determine its effect on more complex multicellular responses. As seen in Fig. 4 , the addition of anti-IL-2 Ig to MLR strongly suppressed T cell multiplication as assessed by [3H]-TdR incorporation, whereas preimmune Ig was without effect. The same pattern was observed in cultures exposed to mitogenic stimulation by Con A: once again, spleen cell proliferation was markedly inhibited by anti-IL-2 Ig (50% reduction of [3H]-TdR labeling at 50 #g]ml of antibody protein) but not by preimmune Ig. The generation of alloreactive CTL on MLR was also affected by anti-IL-2 antibody (Fig. 5) . 
Effect of Anti-IL-2 on T Cell Helper Activity. Previous work (7) has shown that
IV
Specificity of a-IL-2 Immunoabsorption
Lymphokine Source of factor Supernatants were applied to a a-IL-2 lgG Sepharose column. Aliquots of the fractions were tested for lymphokines activity. • ~;0 Results are expressed respectively as U/ml of IL-2, IL-3, and IFN activity. purified IL-2 could promote antibody production in cultures of nude mouse spleen cells. The availability of specific antibody enabled us to test whether IL-2 was actually produced and required under ordinary conditions of assay for antibody synthesis in culture. The addition of antibody significantly reduced the plaque-forming titer of spleen cultures exposed to SRBC (Fig. 6) . The inhibitory action of antibody was equally pronounced (70-85% reduction in plaque number) when the antibodies were added together with SRBC, at time 0 or after two days of culture (Fig. 6 ). When antibody was added to the cultures for the first 2 d and then removed, there was subsequent full recovery of plaque-forming activity. As expected, the effect of antibody could also be reversed by addition of excess IL-2, and preimmune Ig was inert.
Effect of Anti-IL-2 In Vivo.
In view of the preceding results, that anti-IL-2 specifically affect IL-2, and not other cytokines, and could block the MLR, it seems desirable to explore the consequences of injected antibodies in situ, particularly since this might produce evidence about a possible role for IL-2 in modulating T cell functions in vivo. We used an immunization protocol known to generate alloreactive CTL in vivo (13) , in the course of which some of the mice received daily injections of anti-IL-2 Ig, while control mice were injected either with saline or with preimmune Ig. Control determinations were performed to assess the level of circulating anti-IL-2 and stable titers of circulating activity against Cr-labeled EL-4 target in a 4-h cytotoxicity assay. Lymph nodes draining control footpads which were not inoculated with antigen gave no detectable cytotoxic response (<10 s's C.U/node). Experiments were repeated 5 times with no significant difference in the results.
were observed throughout the course of the experiments. As seen in Fig. 7 , lymph node cells from mice injected with anti-IL-2 Ig showed a significant reduction of specific CTL responses to allogeneic cells compared with lymphoid cells from mice that were injected with saline or with preimmune antibody. The cytolytic activity mediated by the lymph node cells was specific for the immunized aliogeneic cell type, as shown by the fact that inappropriate target cells were not lysed. These results strongly implicate IL-2 function during specific cytotoxic T cell responses in situ.
Discussion Our results show that the anti-IL-2 antibodies that we have raised in rabbits are potentially useful reagents both for isolating mouse IL-2 and for probing the functions of this molecule in immune phenomena in vivo and in vitro.
The antibodies were raised in response to injection of highly purified antigen; they are highly specific and may well even be monospecific, but we have not rigorously established this. The elution of three bands of protein from the immunoaffinity column might cast some doubt on the monospecificity of the Ig, but nonspecific absorption of protein to immunoaffinity columns is a well-known phenomenon; furthermore, the presence of IL'2 sequences in the apparent contaminants have not yet been excluded, and additional experiments are required to characterize antibody specificity in greater detail. In spite of this uncertainty, it is clear that the antibodies effectively remove all detectable IL-2 activity from solution and precipitate a protein whose migration on SDS-PAGE is indistinguishable from that of authentic IL-2; further, whatever the limitations of their specificity, the antibodies do not interact with the other lymphokines such as IL-1, IL-3, 3,-IFN, or B cell stimulating factor(s) or cytotoxic differentiation factor(s).
The anti-IL-2 antisera and the Ig purified from them inhibited a variety of immune responses. These included antigen-and lectin-stimulated T cell mitogenesis, IL-2-dependent lymphoblast proliferation, cytotoxic lymphocyte generation in culture, and T cell helper function in an assay for antibody production in culture. In addition, the antibodies reduced the development of alloreactive cytotoxic cells in vivo; this finding is, so far as we are aware, the first direct evidence that endogenous IL-2 may be important for cytotoxic T cell development in vivo. Since this and other responses occur only in mixtures of cells and relatively complex media, the availability of anti-IL-2 should facilitate the further dissection of the cellular and hormonal pathways that mediate these reactions both in vivo and in vitro. The antibodies are therefore likely to be useful as a mechanistically specific immunosuppressive agent in experimental contexts involving a wide range of immune phenomena. They should also be of value in other contexts where tests for IL-2 are needed; these include studies of biosynthesis of IL-2, and the molecular cloning of its cDNA. Summary Antibodies to highly purified mouse interleukin 2 (IL-2) were raised in rabbits; a 1:500 dilution of antiserum completely blocked the in vitro mitogenic effect of 10 -9 M IL-2. The antisera functioned effectively to immunoprecipitate biosynthetically labeled IL-2 and the purified immunoglobulins were useful in the construction of affinity columns for the adsorption and one-step immunopurification of IL-2. The antibodies were apparently specific for IL-2 among the lymphokines, they did not block the biological effects of IL-1, IL-3, "r-IFN, B cell stimulating factor(s), and cytotoxic T cell differentiation factor(s).
When anti-IL-2 was added to the in vitro reactions, it blocked mixed leukocyte reactions (MLR) and associated lymphocyte proliferation, the in vitro generation of cytotoxic T cells, and antibody formation as assessed by erythrocyte-specific plaque-forming cells (PFC).
When injected into mice, anti-IL-2 antibodies also reduced the formation of cytotoxic lymphocytes in response to allogeneic cells, suggesting that endogenous IL-2 participates in such reactions in vivo.
Taken together, the results indicate that these IL-2 antibodies will be useful adjuncts in the analysis of immune response both in vivo and in vitro.
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